Pharmaceutical Deal Archives

Biotech Blockbuster: Biogen Pays Up to $1.06 Billion to License Vanqua Bio’s Immune Disorder Drug

Major biotechnology firm Biogen has signed a massive deal, agreeing to license an immune disorder drug from the smaller company Vanqua Bio. The total value of the deal could reach $1.06 billion. Biogen will gain the rights to develop and sell Vanqua Bio’s experimental drug, which is aimed at treating a serious immune disorder. The…

China's Innovent signs a $1.14B cancer therapy deal with Japan's Takeda, boosting global oncology research.

China’s Innovent Strikes $1.14 Billion Cancer Drug Deal with Pharma Giant Takeda

Aisha Ajaz3 weeks ago3 weeks ago01 mins

hinese biotech company Innovent Biologics has signed a massive deal with Japan’s Takeda Pharmaceutical. The agreement is valued up to $1.14 billion. This partnership focuses on developing and commercializing a promising new cancer therapy. This collaboration highlights the growing importance of China’s biomedical sector. Innovent will lead the development and regulatory filings in mainland China….

Trending News

Business

Technology

AI

AI

Technology

Health

Tag: Pharmaceutical Deal

Biotech Blockbuster: Biogen Pays Up to $1.06 Billion to License Vanqua Bio’s Immune Disorder Drug

China’s Innovent Strikes $1.14 Billion Cancer Drug Deal with Pharma Giant Takeda